Trial NCT03197506

View at ClinicalTrials.gov 
Org. Study IDs: MC1572
Secondary IDs: MC1572 NCI-2017-01106

Last trial update was posted on 2023-10-02

MeSH Interventions

Pembrolizumab Temozolomide

MeSH Conditions

Glioblastoma Gliosarcoma

Other Conditions

Supratentorial Glioblastoma

Stopping Reasons

Temporary closure per protocol design

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID